Da Hee Han, PharmD

Most Recent Articles by Da Hee Han, PharmD

RAS Inhibitor Use May Cut Risk of MI in Rheumatoid Arthritis Patients

By Dec 08, 2017

The use of angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) was associated with a reduced risk of myocardial infarction (MI) among patients with rheumatoid arthritis (RA).

Antiretroviral Combination Linked to Increased CKD Risk

By Dec 08, 2017

The risk of chronic kidney disease (CKD) may be increased in patients living with HIV receiving tenofovir (TDF) with a ritonavir-boosted protease inhibitor compared to those who receive TDF with a non-nucleosidic reverse transcriptase inhibitor (NNRTI)

Do Certain Medications Increase the Risk of MS Development?

By Dec 07, 2017

No drug treatments were conclusively associated with an increased risk of MS.

First Nebulized LAMA Approved for COPD

By Dec 06, 2017

Adults treated with Lonhala Magnair showed statistically significant and clinically important changes from baseline in trough forced expiratory volume in 1 second (FEV1) at Week 12 vs placebo.

Avastin Gains Full FDA Approval for Recurrent Glioblastoma

By Dec 06, 2017

The conversion from provisional to full approval was based on totality of evidence of Avastin in glioblastoma.

More Articles by Da Hee Han, PharmD